Rapid Sequencing May Alleviate Sequencing Challenges in mCRPC
Published: Friday, Mar 20, 2020
William Oh, MD
The optimal sequencing of therapies for patients with metastatic castration-resistant prostate cancer (mCRPC) has proven to be a significant clinical challenge following the approvals of additional agents, said William K. Oh, MD.
... to read the full story